AKBA Akebia Therapeutics, Inc. - Common Stock

NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗
$0,86
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 5, 2026

AKBA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$0.86
Marktkapitalisierung
$230M
P/E (TTM)
-43.4
EPS (TTM)
$-0.02
Umsatz (TTM)
$236M
Dividendenrendite
ROE
-17.3%
Verschuldungsgrad
1.5
52W-Spanne
$1 – $3

AKBA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $236M
6-point trend, -19.8%
2020-12-31 2025-12-31
EPS $-0.02
6-point trend, +99.3%
2020-12-31 2025-12-31
Freier Cashflow $68M
6-point trend, +161.2%
2020-12-31 2025-12-31
Margen -2.3%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
AKBA
Peer-Median
P/E (TTM)
5-point trend, -5955.4%
-43.4
88.5
P/S (TTM) (K/V (TTM))
5-point trend, +28.6%
1.0
1.7
P/B (K/B)
5-point trend, +682.6%
7.1
3.6
EV / EBITDA
5-point trend, +1740.9%
4.0
Price / FCF (Kurs / FCF)
5-point trend, +268.5%
3.4

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
AKBA
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, +108.0%
10.0%
Net Profit Margin (Nettogewinnmarge)
5-point trend, +98.3%
-2.3%
-35.8%
ROA
5-point trend, +96.7%
-1.8%
-38.8%
ROE
5-point trend, +87.2%
-17.3%
-61.0%
ROIC
3-point trend, +138.1%
41.7%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
AKBA
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
5-point trend, +280.2%
1.5
0.0
Current Ratio (Liquiditätsgrad)
5-point trend, -21.8%
1.6
3.9
Quick Ratio
5-point trend, +4.2%
1.4

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
AKBA
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, +11.6%
47.5%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, +11.6%
-6.9%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, +11.6%
-4.3%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
AKBA
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, +98.8%
$-0.02

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
AKBA
Peer-Median

AKBA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 11 Analysten
  • Starker Kauf 5 45,5%
  • Kauf 5 45,5%
  • Halten 1 9,1%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

5 Analysten · 2026-08-15
Median-Ziel $4.00 +365,3%
Mittelwert-Ziel $3.80 +342,1%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.02%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $-0.03 $-0.04 0.01%
31. März 2026 $-0.03 $-0.03 -0.00%
31. Dezember 2025 $-0.05 $-0.03 -0.02%
30. September 2025 $0.00 $-0.02 0.02%
30. Juni 2025 $0.00 $-0.02 0.02%
31. März 2025 $0.03 $-0.05 0.08%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
AKBA $427M -80.5 47.5% -2.3% -17.3%
CNXU
GLSI $300M -14.7 -2159.7%
PYXS $72M -0.9 -14.2% -574.5% -112.9%
RCEL $105M -2.0 11.5% -67.8% 328.9% 82.1%
TARA $286M -4.0 -33.7%
ALEC $172M -1.1 -79.1% -679.2% -280.7%
EBS $644M 13.3 -28.8% 7.1% 9.9%
ARCT $174M -2.6 -46.1% -80.2% -29.6%
NBP
IMUX -0.9

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 16
Jährliche Gewinn- und Verlustrechnung-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +236196000.00 $236M $160M $195M $292M $212M $295M $335M $208M $181M $2M $0 $0
Cost of Revenue 8-point trend, +408.0% $39M $63M $74M $86M $151M $296M $145M $8M · · · ·
R&D Expense 12-point trend, +168.1% $62M $38M $63M $130M $148M $218M $323M $291M $231M $116M $43M $23M
SG&A Expense 12-point trend, +632.3% $107M $107M $100M $139M $174M $154M $149M $87M $27M $22M $18M $15M
Operating Expenses 12-point trend, +356.6% $173M $147M $167M $288M $325M $376M $476M $378M $258M $138M $62M $38M
Operating Income 12-point trend, +161.9% $23M $-50M $-46M $-81M $-265M $-378M $-286M $-178M $-77M $-136M $-62M $-38M
Interest Income 3-point trend, +337.4% · · · · · · · · · $901.0K $510.0K $206.0K
Other Non-op 12-point trend, -91.7% $58.0K $94.0K $887.0K $3M $2M $2M $-794.0K $81.0K $204.0K $-188.0K $287.0K $700.0K
Pretax Income 10-point trend, +97.3% $-4M $-69M $-52M $-94M $-282M $-385M $-286M $-172M $-74M $-136M · ·
Income Tax 8-point trend, +105.7% $2M $0 $0 $0 $0 $0 $-7M $-28M · · · ·
Net Income 12-point trend, +85.6% $-5M $-69M $-52M $-94M $-282M $-385M $-280M $-144M $-74M $-136M $-61M $-37M
EPS (Basic) 7-point trend, +99.2% $-0.02 $-0.33 $-0.28 $-0.52 $-1.70 $-2.78 $-2.36 · · · · ·
EPS (Diluted) 7-point trend, +99.2% $-0.02 $-0.33 $-0.28 $-0.52 $-1.70 $-2.78 $-2.36 · · · · ·
Shares (Basic) 7-point trend, +117.2% 257,157,782 210,946,658 187,465,448 182,782,680 165,949,695 138,463,152 118,395,919 · · · · ·
Shares (Diluted) 7-point trend, +117.2% 257,157,782 210,946,658 187,465,448 182,782,680 165,949,695 138,463,152 118,395,919 · · · · ·
EBITDA 12-point trend, +161.9% $23M $-50M $-46M $-79M $-263M $-374M $-284M $-177M $-79M $-136M $-62M $-38M
Bilanz 29
Jährliche Bilanz-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +463.9% $185M $52M $43M $90M $150M $229M $147M $105M $70M $187M $50M $33M
Short-term Investments 4-point trend, +225.2% · · · · · · · · $248M $73M $89M $76M
Receivables 11-point trend, +97881.2% $47M $34M $39M $40M $52M $27M $39M $17M $34M $34M · $48.0K
Inventory 8-point trend, -86.3% $16M $16M $16M $22M $37M $61M $116M $114M · · · ·
Prepaid Expense 12-point trend, +250.2% $5M $11M $20M $33M $33M $15M $7M $16M $6M $2M $3M $2M
Other Current Assets 4-point trend, -78.1% $4M $7M $6M $17M · · · · · · · ·
Current Assets 12-point trend, +129.0% $253M $114M $118M $185M $271M $371M $310M $468M $358M $296M $141M $110M
PP&E (Net) 12-point trend, +481.9% $1M $2M $4M $5M $7M $9M $10M $8M $4M $3M $540.0K $210.0K
PP&E (Gross) 9-point trend, +5468.2% · · · $15M $14M $14M $14M $10M $5M $3M $687.0K $261.0K
Accum. Depreciation 9-point trend, +18172.5% · · · $9M $8M $6M $4M $2M $1M $442.0K $147.0K $51.0K
Goodwill 8-point trend, +7.2% $59M $59M $59M $59M $59M $55M $55M $55M · · · ·
Intangibles 7-point trend, -100.0% · $0 $36M $72M $108M $144M $291M $328M · · · ·
Other Non-current Assets 12-point trend, +19467.5% $60M $37M $12M $5M $50M $38M $76M $137M $2M $1M $1M $305.0K
Total Assets 12-point trend, +239.3% $377M $221M $242M $356M $529M $644M $771M $997M $364M $300M $143M $111M
Accounts Payable 12-point trend, +948.2% $21M $15M $15M $18M $34M $41M $39M $43M $7M $2M $2M $2M
Accrued Liabilities 12-point trend, +2402.4% $122M $63M $68M $76M $109M $131M $129M $151M $52M $30M $10M $5M
Current Liabilities 12-point trend, +2266.6% $163M $81M $100M $130M $261M $187M $208M $266M $141M $114M $12M $7M
Capital Leases 7-point trend, -100.0% $0 $4M $9M $29M $34M $25M $28M · · · · ·
Other Non-current Liabilities 12-point trend, +5596.9% $2M $5M $9M $16M $84M $61M $30M $30M $22.0K $27.0K $5.0K $32.0K
Total Liabilities 12-point trend, +4872.6% $344M $270M $272M $351M $455M $397M $376M $361M $242M $232M $12M $7M
Long-term Debt 7-point trend, -36.3% $48M $39M $35M $66M $98M $96M $76M · · · · ·
Total Debt 6-point trend, -36.3% $48M $39M $35M · $98M $96M $76M · · · · ·
Common Stock 12-point trend, +2000.00 $2.0K $2.0K $2.0K $2.0K $1.0K $1.0K $1.0K $1.0K $0 $0 $0 $0
Retained Earnings 12-point trend, -1572.4% $-1.68B $-1.68B $-1.61B $-1.56B $-1.46B $-1.18B $-794M $-514M $-371M $-297M $-161M $-101M
Treasury Stock Flat — no change across 2 periods · · · · · · · · · · $162.0K $162.0K
AOCI 12-point trend, +110.7% $6.0K $6.0K $6.0K $6.0K $6.0K $13.0K $0 $-261.0K $-442.0K $-42.0K $-234.0K $-56.0K
Stockholders' Equity 12-point trend, -68.7% $33M $-49M $-31M $5M $74M $244M $393M $636M $123M $68M $131M $104M
Liabilities + Equity 12-point trend, +239.3% $377M $221M $242M $356M $529M $644M $771M $997M $364M $300M $143M $111M
Shares Outstanding 12-point trend, +1203.0% 265,424,818 224,848,992 194,582,539 184,135,714 177,000,963 148,074,085 121,674,568 116,887,518 47,612,619 38,615,709 30,662,218 20,370,624
Cashflow 17
Jährliche Cashflow-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A 9-point trend, +3275.5% · · · $2M $2M $2M $2M $899.0K $617.0K $296.0K $96.0K $49.0K
Stock-based Comp 12-point trend, +87.7% $11M $8M $9M $18M $23M $24M $12M $19M $9M $6M $5M $6M
Deferred Tax 12-point trend, +0.00 $0 $0 $0 $0 $0 $0 $-7M $-28M $0 $0 $0 $0
Amort. of Intangibles 8-point trend, -100.0% $0 $36M $36M $36M $36M $33M $36M $2M · · · ·
Restructuring 6-point trend, +0.00 $0 $58.0K $181.0K $16M $0 $0 · · · · · ·
Other Non-cash 7-point trend, -99.2% · · · $2M $5M $247M $15M $55M $11M $188M · ·
Operating Cash Flow 12-point trend, +347.4% $68M $-41M $-23M $-73M $-253M $-110M $-257M $-97M $-56M $58M $-52M $-27M
CapEx 12-point trend, +27.1% $291.0K $33.0K $0 $114.0K $59.0K $317.0K $7M $2M $2M $3M $414.0K $229.0K
Investing Cash Flow 10-point trend, -162.4% $-8M $-33.0K $0 $-114.0K $40M $-40M $211M $37M $-177M $13M · ·
Debt Issued 5-point trend, +0.00 · · · $0 $0 $20M $78M $0 · · · ·
Net Debt Issued 4-point trend, -100.0% · · · $0 $0 $20M $78M · · · · ·
Stock Issued 3-point trend, +349.0% · · · · · · · $468M $373M · · $104M
Stock Repurchased · · · · · · · · · · · $162.0K
Net Stock Activity 3-point trend, +349.7% · · · · · · · $468M $373M · · $104M
Financing Cash Flow 10-point trend, +8.9% $73M $50M $-25M $15M $134M $232M $89M $97M $116M $67M · ·
Net Change in Cash 12-point trend, +1050.0% $133M $9M $-49M $-59M $-79M $81M $43M $36M $-117M $138M $17M $12M
Free Cash Flow 12-point trend, +344.3% $68M $-41M $-23M $-73M $-253M $-111M $-264M $-99M $-58M $55M $-53M $-28M
Rentabilität 7
Jährliche Rentabilität-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Operating Margin 8-point trend, +111.6% 10.0% -31.5% -23.8% -27.6% -124.2% -127.5% -85.5% -85.8% · · · ·
Net Margin 8-point trend, +96.7% -2.3% -43.3% -26.7% -32.2% -132.4% -129.8% -83.5% -69.1% · · · ·
Pretax Margin 8-point trend, +98.1% -1.6% -43.3% -26.7% -32.2% -132.4% -129.8% -85.5% -82.8% · · · ·
EBITDA Margin 8-point trend, +111.7% 10.0% -31.5% -23.8% -27.1% -123.3% -126.8% -84.8% -85.3% · · · ·
ROA 11-point trend, +96.5% -1.8% -30.0% -19.9% · -48.4% -54.2% -31.6% -21.1% -23.2% -61.3% -47.8% -50.8%
ROE 11-point trend, -105.4% -17.3% 139.4% 148.3% · -264.8% -135.6% -64.9% -36.9% -82.1% -136.3% -51.7% 322.1%
ROIC 5-point trend, +278.4% 41.7% · · · -152.5% -109.4% -59.4% -23.4% · · · ·
Liquidität & Solvenz 4
Jährliche Liquidität & Solvenz-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -90.3% 1.6 1.4 1.2 · 1.1 2.0 1.5 1.8 2.5 2.6 11.9 16.0
Quick Ratio 11-point trend, -91.0% 1.4 1.1 0.8 · 0.8 1.4 0.9 0.5 2.4 2.3 11.7 15.8
Debt / Equity 6-point trend, +670.6% 1.5 -0.8 -1.1 · 1.3 0.4 0.2 · · · · ·
LT Debt / Equity 6-point trend, +670.6% 1.5 -0.8 -0.6 · 0.0 0.4 0.2 · · · · ·
Effizienz 3
Jährliche Effizienz-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 9-point trend, +0.79 0.8 0.7 0.7 · 0.4 0.4 0.4 0.3 · · 0.0 0.0
Inventory Turnover 7-point trend, +2164.9% 2.5 4.0 4.1 · 3.1 3.3 0.9 0.1 · · · ·
Receivables Turnover 8-point trend, +5.80 5.8 4.3 6.7 · 5.5 9.0 12.1 8.2 · · · 0.0
Pro Aktie 5
Jährliche Pro Aktie-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share 11-point trend, -97.6% $0.12 $-0.22 $-0.16 · $0.43 $1.67 $3.24 $5.44 $2.51 $1.76 $4.27 $5.11
Revenue / Share 5-point trend, -28.6% $0.92 $0.76 $1.04 $1.60 $1.29 · · · · · · ·
Cash Flow / Share 5-point trend, +117.3% $0.26 $-0.19 $-0.12 $-0.40 $-1.52 · · · · · · ·
Cash / Share 11-point trend, -56.7% $0.70 $0.23 $0.22 · $0.85 $1.54 $1.21 $0.90 $1.47 $4.85 $1.62 $1.61
EPS (TTM) 9-point trend, +98.9% $-0.02 $-0.33 $-0.28 $-0.52 $-1.70 $-2.78 $-2.36 $-1.86 $-1.86 · · ·
Wachstumsraten 3
Jährliche Wachstumsraten-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +268.5% 47.5% -17.7% -33.5% 38.2% -28.2% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +46.7% -6.9% -8.9% -12.9% · · · · · · · · ·
Revenue CAGR 5Y -4.3% · · · · · · · · · · ·
Bewertung (TTM) 14
Jährliche Bewertung (TTM)-Daten für AKBA
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +236196000.00 $236M $160M $195M $292M $212M $295M $335M $208M $181M $2M $0 $0
Net Income TTM 12-point trend, +85.6% $-5M $-69M $-52M $-94M $-282M $-385M $-280M $-144M $-74M $-136M $-61M $-37M
Market Cap 11-point trend, +80.2% $427M $427M $241M · $400M $415M $769M $646M $708M $402M $396M $237M
Enterprise Value 6-point trend, -58.3% $291M $414M $233M · $348M $282M $697M · · · · ·
P/E 9-point trend, -906.9% -80.5 -5.8 -4.4 -1.1 -1.3 -1.0 -2.7 -3.0 -8.0 · · ·
P/S 9-point trend, -99.3% 1.8 2.7 1.2 · 1.9 1.4 2.3 3.1 3.9 261.9 · ·
P/B 11-point trend, +475.2% 13.1 -8.7 -7.9 · 5.2 1.7 1.9 1.0 5.9 5.9 3.0 2.3
P / Tangible Book · · · · · 9.2 · · · · · ·
P / Cash Flow 11-point trend, +172.8% 6.3 -10.5 -10.3 · -1.6 -3.8 -3.0 -6.6 -12.6 6.9 -7.6 -8.6
P / FCF 11-point trend, +173.8% 6.3 -10.5 -10.3 · -1.6 -3.7 -2.9 -6.5 -12.3 7.3 -7.5 -8.6
EV / EBITDA 6-point trend, +604.0% 12.4 -8.2 -5.0 · -1.3 -0.8 -2.5 · · · · ·
EV / FCF 6-point trend, +262.6% 4.3 -10.2 -10.0 · -1.4 -2.5 -2.6 · · · · ·
EV / Revenue 6-point trend, -40.9% 1.2 2.6 1.2 · 1.6 1.0 2.1 · · · · ·
Earnings Yield 9-point trend, +90.1% -1.2% -17.4% -22.6% -90.1% -75.2% -99.3% -37.3% -33.6% -12.5% · · ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312023-03-312022-12-31
Umsatz $236M$160M$195M$292M
Betriebsgewinnmarge % 10.0%-31.5%-23.8%-27.6%
Nettoergebnis $-5M$-69M$-52M$-94M
Verwässerte EPS $-0.02$-0.33$-0.28$-0.52
Bilanz
2025-12-312024-12-312023-12-312023-03-312022-12-31
Fremdkapital / Eigenkapital 1.5-0.8-1.1
Liquiditätsgrad 1.61.41.2
Quick Ratio 1.41.10.8
Cashflow
2025-12-312024-12-312023-12-312023-03-312022-12-31
Freier Cashflow $68M$-41M$-23M$-73M

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 184 Einreicher · $87.7M gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
43 (+12 vs. Vorquartal) 35 (+9 vs. Vorquartal) 59 (+14 vs. Vorquartal) 36 (-14 vs. Vorquartal) +11.5M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
VANGUARD CAPITAL MANAGEMENT LLC $12.907.243 11.322.143 14,72% Aktien
SATTER MANAGEMENT CO., L.P. $10.921.021 5.747.906 12,45% Aktien
GEODE CAPITAL MANAGEMENT, LLC $6.557.737 5.750.625 7,48% Aktien
STATE STREET CORP $6.145.572 5.390.853 7,01% Aktien
JACOBS LEVY EQUITY MANAGEMENT, INC $4.871.250 4.273.026 5,55% Aktien
MILLENNIUM MANAGEMENT LLC $3.644.130 3.196.605 4,15% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $2.888.734 2.533.977 3,29% Aktien
GOLDMAN SACHS GROUP INC $2.779.842 2.438.458 3,17% Aktien
TWO SIGMA INVESTMENTS, LP $2.777.807 2.436.673 3,17% Aktien
VANGUARD GROUP INC $2.715.740 1.686.795 3,10% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $2.622.499 2.300.438 2,99% Aktien
Nantahala Capital Management, LLC $2.280.000 2.000.000 2,60% Aktien
VANGUARD FIDUCIARY TRUST CO $2.176.029 1.908.797 2,48% Aktien
FMR LLC $2.132.467 1.870.585 2,43% Aktien
Qube Research & Technologies Ltd $2.028.866 1.779.707 2,31% Aktien
RENAISSANCE TECHNOLOGIES LLC $1.395.318 1.223.963 1,59% Aktien
CITIGROUP INC $1.265.009 1.109.657 1,44% Aktien
MANGROVE PARTNERS IM, LLC $760.328 666.954 0,87% Aktien
AMERIPRISE FINANCIAL INC $703.205 616.846 0,80% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $672.396 589.821 0,77% Aktien
TWO SIGMA ADVISERS, LP $643.918 399.949 0,73% Aktien
CHOREO, LLC $641.162 562.423 0,73% Aktien
Quantinno Capital Management LP $640.820 562.123 0,73% Aktien
Creative Planning $622.144 545.740 0,71% Aktien
LOS ANGELES CAPITAL MANAGEMENT LLC $606.265 531.813 0,69% Aktien
MORGAN STANLEY $584.591 512.799 0,67% Aktien
PANAGORA ASSET MANAGEMENT INC $531.832 466.519 0,61% Aktien
ALLIANCEBERNSTEIN L.P. $493.325 354.910 0,56% Aktien
Eversept Partners, LP $486.888 427.095 0,56% Aktien
BANK OF AMERICA CORP /DE/ $473.308 415.182 0,54% Aktien
CANADA PENSION PLAN INVESTMENT BOARD $368.904 323.600 0,42% Aktien
VIRTUS ADVISERS, LLC $359.940 315.737 0,41% Aktien
RHUMBLINE ADVISERS $350.544 307.503 0,40% Aktien
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $336.186 294.900 0,38% Aktien
ALPS ADVISORS INC $310.379 272.262 0,35% Aktien
DIMENSIONAL FUND ADVISORS LP $307.391 269.641 0,35% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $304.722 267.300 0,35% Verkaufsoption
FRANKLIN RESOURCES INC $286.156 251.014 0,33% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $279.072 244.800 0,32% Kaufoption
Vanguard Global Advisers, LLC $251.440 220.561 0,29% Aktien
Graham Capital Management, L.P. $236.845 207.759 0,27% Aktien
Bank of New York Mellon Corp $227.323 199.406 0,26% Aktien
Wealthspire Advisors, LLC $205.203 180.002 0,23% Aktien
CITADEL ADVISORS LLC $190.608 167.200 0,22% Verkaufsoption
BlackRock, Inc. $189.909 166.587 0,22% Aktien
Nuveen Asset Management, LLC $186.464 98.139 0,21% Aktien
Man Group plc $177.151 155.396 0,20% Aktien
Mariner, LLC $175.851 154.256 0,20% Aktien
MetLife Investment Management, LLC $174.281 152.878 0,20% Aktien
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $157.464 112.474 0,18% Aktien
Russell Investments Group, Ltd. $143.655 126.014 0,16% Aktien
BARCLAYS PLC $139.430 122.307 0,16% Aktien
VIRGINIA RETIREMENT SYSTEMS ET Al $136.850 85.000 0,16% Aktien
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $135.666 119.005 0,15% Aktien
MERCER GLOBAL ADVISORS INC /ADV $127.402 111.756 0,15% Aktien
Invesco Ltd. $116.967 102.603 0,13% Aktien
GROUP ONE TRADING LLC $115.841 101.615 0,13% Aktien
Fiduciary Trust Co $114.000 100.000 0,13% Aktien
CITADEL ADVISORS LLC $110.580 97.000 0,13% Kaufoption
LPL Financial LLC $108.888 95.516 0,12% Aktien
IEQ CAPITAL, LLC $105.312 92.379 0,12% Aktien
Jain Global LLC $104.214 91.416 0,12% Aktien
Focus Partners Wealth $92.280 80.948 0,11% Aktien
BNP PARIBAS FINANCIAL MARKETS $91.133 79.941 0,10% Aktien
NEW YORK STATE COMMON RETIREMENT FUND $90.174 79.100 0,10% Aktien
Headlands Technologies LLC $88.911 77.992 0,10% Aktien
Abel Hall, LLC $85.999 75.438 0,10% Aktien
SEI INVESTMENTS CO $84.797 74.383 0,10% Aktien
D. E. Shaw & Co., Inc. $82.699 72.543 0,09% Aktien
MANUFACTURERS LIFE INSURANCE COMPANY, THE $81.957 71.892 0,09% Aktien
OSAIC HOLDINGS, INC. $79.715 69.926 0,09% Aktien
Police & Firemen's Retirement System of New Jersey $78.757 69.085 0,09% Aktien
Brevan Howard Capital Management LP $72.675 63.750 0,08% Aktien
CITADEL ADVISORS LLC $72.243 63.371 0,08% Aktien
INTECH INVESTMENT MANAGEMENT LLC $70.931 62.220 0,08% Aktien
Squarepoint Ops LLC $67.747 59.427 0,08% Aktien
CWA Asset Management Group, LLC $67.260 59.000 0,08% Aktien
RAYMOND JAMES FINANCIAL INC $65.585 57.531 0,07% Aktien
WELLINGTON MANAGEMENT GROUP LLP $63.105 55.355 0,07% Aktien
Arax Advisory Partners $62.700 54.999 0,07% Aktien
VOYA INVESTMENT MANAGEMENT LLC $61.941 54.334 0,07% Aktien
CAPTRUST FINANCIAL ADVISORS $61.567 54.006 0,07% Aktien
JANE STREET GROUP, LLC $59.280 52.000 0,07% Kaufoption
PDS Planning, Inc $57.000 50.000 0,06% Aktien
Nuveen, LLC $56.925 49.934 0,06% Aktien
UBS Group AG $52.834 46.346 0,06% Aktien
PRUDENTIAL FINANCIAL INC $50.028 43.884 0,06% Aktien
NORTHERN TRUST CORP $46.146 40.479 0,05% Aktien
TWO SIGMA SECURITIES, LLC $45.753 40.134 0,05% Aktien
EP Wealth Advisors, LLC $44.059 38.648 0,05% Aktien
HighTower Advisors, LLC $43.968 38.568 0,05% Aktien
Gotham Asset Management, LLC $41.100 36.053 0,05% Aktien
Scientech Research LLC $40.117 35.190 0,05% Aktien
Empirical Asset Management, LLC $39.900 35.000 0,05% Aktien
ProShare Advisors LLC $38.572 33.836 0,04% Aktien
NEUBERGER BERMAN GROUP LLC $37.783 33.143 0,04% Aktien
CWM, LLC $36.332 26.138 0,04% Aktien
Tower Research Capital LLC (TRC) $35.706 31.321 0,04% Aktien
VICTORY CAPITAL MANAGEMENT INC $34.394 30.170 0,04% Aktien
Sonora Investment Management Group, LLC $32.760 12.000 0,04% Aktien

Unternehmensinsider 29 Insider · 9 Führungskräfte · 17 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Erik Ostrowski SVP, CFO, CBO & Treasurer 29. Juni 2026 S 616.616 0 1 $-62.181
David A Spellman SVP, CFO and Treasurer 30. Juni 2020 A 0 0 $0
Jason Amello SVP, CFO & Treasurer 11. April 2019 D 118.618 0 0 $0
Rita Jain SVP, Chief Medical Officer 11. April 2019 D 96.332 0 0 $0
Michel Dahan SVP, Chief Business Officer 11. April 2019 D 146.932 0 0 $0
Nicole R. Hadas SVP, CLO & Secretary 11. April 2019 D 154.806 0 0 $0
Karen L Tubridy SVP, Chief Development Officer 11. April 2019 D 55.324 0 0 $0
Bradley Maroni SVP and Chief Medical Officer 22. Februar 2016 A 38.859 0 0 $0
Robert Shalwitz Chief Medical Officer 14. Mai 2014 A 264.556 0 0 $0
Ron Frieson Direktor 17. Juni 2026 A 165.200 0 0 $0
Myles Wolf Direktor 17. Juni 2026 A 169.081 0 0 $0
Cynthia Smith Direktor 17. Juni 2026 A 196.633 0 0 $0
Adrian Adams Direktor 17. Juni 2026 A 236.200 0 0 $0
Michael W Rogers Direktor 17. Juni 2026 A 197.429 0 0 $0
Leanne M Zumwalt Direktor 17. Juni 2026 A 145.100 0 0 $0
Jodie Pope Morrison Direktor 12. Dezember 2018 A 44.919 0 0 $0
Mark J Enyedy Direktor 12. Dezember 2018 A 3.743 0 0 $0
Michael Thomas Heffernan Direktor 12. Dezember 2018 A 7.486 0 0 $0
Steven C Gilman Direktor 12. Dezember 2018 A 10.231 0 0 $0
Satter Muneer A Direktor 5. Juli 2017 P 3.037.042 0 0 $0
Duane Nash Direktor 2. Oktober 2015 S 31.609 0 0 $0
Anupam Dalal Direktor 10. Juni 2015 A 0 0 $0
Michael D. Clayman Direktor 10. Juni 2015 A 0 0 $0
Ronald C Renaud JR Direktor 10. Juni 2015 A 5.000 0 0 $0
Maxine Gowen Direktor 10. Juni 2015 A 1.300 0 0 $0
Michael S Wyzga Direktor 10. Juni 2015 A 1.500 0 0 $0
John P. Butler 6. August 2026 M 3.718.564 0 0 $0
Novo Holdings A/S 25. März 2014 C 1.516.387 0 0 $0
Novartis Bioventures Ltd 25. März 2014 C 3.405.764 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 5 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Muneer A. Satter (2) ×3 Einreichungen 11. Januar 2019 Erste Einreichung SEC
Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 Einreichungen 21. Dezember 2018 Erste Einreichung SEC
Vifor (International) Ltd., Vifor Pharma Ltd. ×2 Einreichungen 10. August 2017 Erste Einreichung SEC
Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 Einreichungen 20. Januar 2016 Erste Einreichung SEC
Novo A/S ×3 Einreichungen 18. November 2015 Erste Einreichung SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 30 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
QQQS · Invesco Exchange-Traded Fund Trust … 0,44% 109.760 SH 8. August 2026 Täglich
SBIO · ALPS ETF Trust 0,17% 276.121 NS 31. Mai 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,09% 352.079 NS 30. April 2026 N-PORT
IWC · iShares Trust 0,06% 879.437 SH 8. August 2026 Täglich
GSSC · Goldman Sachs ETF Trust 0,03% 326.417 NS 31. Mai 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0,02% 249.458 SH 8. August 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 450.395 SH 8. August 2026 Täglich
SMLF · iShares Trust 0,01% 617.659 SH 8. August 2026 Täglich
IWO · iShares Trust 0,01% 2.117.247 SH 8. August 2026 Täglich
RSSL · Global X Funds 0,01% 111.420 NS 30. April 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 1.485.665 SH 8. August 2026 Täglich
IWM · iShares Trust 0,01% 6.655.005 SH 8. August 2026 Täglich
ITWO · ProShares Trust 0,01% 11.916 NS 31. Mai 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,01% 1.262.655 NS 31. Mai 2026 N-PORT
UWM · ProShares Trust 0,00% 9.319 NS 31. Mai 2026 N-PORT
URTY · ProShares Trust 0,00% 9.423 NS 31. Mai 2026 N-PORT
IWN · iShares Trust 0,00% 337.593 SH 8. August 2026 Täglich
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 11.769 NS 31. Mai 2026 N-PORT
HDG · ProShares Trust 0,00% 237 NS 31. Mai 2026 N-PORT
ITOT · iShares Trust 0,00% 364.360 SH 8. August 2026 Täglich
DFAC · Dimensional ETF Trust 0,00% 108.459 NS 30. April 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 6.918 NS 30. April 2026 N-PORT
IWV · iShares Trust 0,00% 45.708 SH 8. August 2026 Täglich
DFAU · Dimensional ETF Trust 0,00% 6.798 NS 30. April 2026 N-PORT
DFAS · Dimensional ETF Trust 0,00% 11.776 NS 30. April 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 3.164.884 SH 8. August 2026 Täglich
VTI · VANGUARD INDEX FUNDS 0,00% 7.912.283 SH 8. August 2026 Täglich
VTWV · VANGUARD SCOTTSDALE FUNDS 0,00% 24.210 SH 8. August 2026 Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 20.230 SH 8. August 2026 Täglich
VHT · VANGUARD WORLD FUND 0,00% 754.414 SH 8. August 2026 Täglich